US EditionMedtronic's Diabetes Unit MiniMed Raises $560 Million in US IPO
MiniMed priced 28 million shares at $20 each, with Medtronic retaining about 90% ownership after the IPO to fund corporate needs and repay debt.
- From Galway and Northridge, MiniMed said it priced an IPO of 28,000,000 shares at $20.00 per share on March 4, 2026.
- MiniMed said it will use a portion of net proceeds for general corporate purposes and to repay intercompany debt owed to Medtronic, following the IPO.
- MiniMed's underwriters are granted a 30-day option to purchase up to 4,200,000 additional shares at the IPO price, with bookrunners including Barclays, Deutsche Bank Securities, Mizuho, Wells Fargo Securities, Evercore ISI, and Piper Sandler.
- Medtronic is expected to retain roughly 90.03% ownership after the offering, or 88.70% if the over‑allotment option is exercised, and the offering is expected to close on March 9, 2026 subject to customary closing conditions.
- Regulatory filings warn of material risks including capital market, industry and closing‑condition risks that may affect anticipated benefits, while MiniMed's role in insulin delivery across 80 countries highlights the IPO's wider significance.
12 Articles
12 Articles
The Billings Gazette
MiniMed announces pricing of initial public offering
GALWAY, Ireland and NORTHRIDGE, Calif., March 5, 2026 /PRNewswire/ -- MiniMed Group, Inc. (MiniMed), a subsidiary of Medtronic plc (Medtronic) (NYSE: MDT), today announced the pricing of its initial public
MiniMed (MMED) IPO Falls Flat as Medtronic (MDT) Spinoff Debuts Below Price
TLDR MiniMed (MMED) started trading at $19.05 on Friday, March 6, falling 4.8% below the $20 IPO offering price in its Nasdaq launch. The diabetes technology firm generated $560 million through the sale of 28 million shares — significantly lower than the anticipated $25–$28 pricing range. The opening price established MiniMed’s market capitalization at $5.35 billion. Medtronic (MDT) continues to control approximately 90% ownership following the…
MiniMed to close $644M IPO next week ahead of Medtronic split
MiniMed has set the price for its planned initial public offering (IPO) ahead of an imminent separation from Medtronic (NYSE:MDT). The Medtronic Diabetes unit’s IPO includes 28 million shares of common stock priced at $20 apiece. Underwriters also have an option to purchase up to 4.2 million additional shares at the same price. Altogether, proceeds could reach up to $644 million if exercised in full. MiniMed expects to begin trading on the Nasda…
Coverage Details
Bias Distribution
- 71% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
